Karanjin
Karanjin is an orally active furanoflavonoid which can be isolated from several Leguminosae. Karanjin exhibits evident anti-diabetic, anti-cancer, anti-inflammatory, antioxidant, anticolitis, anti-ulcer, anti-Alzheimer properties and multiple insect repellent/insecticidal, acaricide properties, suggesting the potential of Karanjin to be applied to relevant research[1].
Product Specifications
CAS Number
521-88-0
UNSPSC
12352005
Hazard Statement
H302, H312, H315, H319, H332, H335
Target
AMPK; Apoptosis; Cytochrome P450; NF-κB; Phosphatase
Type
Natural Products
Related Pathways
Apoptosis; Epigenetics; Metabolic Enzyme/Protease; NF-κB; PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer; Endocrinology; Metabolic Disease; Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/karanjin.html
Purity
99.90
Solubility
DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C1C2=CC=C(OC=C3)C3=C2OC(C4=CC=CC=C4)=C1OC
Molecular Formula
C18H12O4
Molecular Weight
292.29
Precautions
H302, H312, H315, H319, H332, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
C6orf150 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
LYVE1, CT (Lymphatic Vessel Endothelial Hyaluronic Acid Receptor 1, Cell Surface Retention Sequence-binding Protein 1, CRSBP-1, Hyaluronic Acid Receptor, Extracellular Link Domain-containing Protein 1, LYVE-1, CRSBP1, HAR, XLKD1, UNQ230/PRO263) (MaxLight
LYVE1, CT (Lymphatic Vessel Endothelial Hyaluronic Acid Receptor 1, Cell Surface Retention Sequence-binding Protein 1, CRSBP-1, Hyaluronic Acid Receptor, Extracellular Link Domain-containing Protein 1, LYVE-1, CRSBP1, HAR, XLKD1, UNQ230/PRO263) (MaxLight
Frizzled 7 Polyclonal Antibody, AbBy Fluor™ 750 Conjugated